GHK-CU/BPC-157/TB-500/KPV 50/10/10/10mg Blend

Description

Product Name:
KLOW (Multi-Peptide Complex)

Chemical Information of KLOW Blend 80mg

• Composition per Vial:

  • GHK-Cu: 50 mg

  • BPC-157: 10 mg

  • TB-500 (Thymosin Beta-4 fragment): 10 mg

  • KPV (Lys-Pro-Val): 10 mg

• Molecular Formula:

  • GHK-Cu: C14H24CuN6O4

  • BPC-157: C62H98N16O22

  • TB-500 fragment (17AA): C77H128N22O18S

  • KPV: C17H28N4O5

• CAS Numbers:
  • GHK-Cu: 49557-75-7
  • BPC-157: 137525-51-0
  • TB-500: 77591-33-4
  • KPV: 67727-97-3

• Molecular Weight:

  • GHK-Cu: 403.86 g/mol

  • BPC-157: 1419.54 g/mol

  • TB-500 fragment (17AA): 1529.7 g/mol

  • KPV: 384.43 g/mol

• Sequence:

  • GHK-Cu: Gly-His-Lys (copper bound)

  • BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

  • TB-500 fragment: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Leu-Lys-Glu-Lys

  • KPV: Lys-Pro-Val

• Molecular Structure: Refer to Certificate of Analysis for detailed structural information.

Storage and Handling of KLOW Blend 80mg

• Store sealed at recommended laboratory freezer temperatures.

• Protect from light, moisture, and excessive heat.

• Handle using standard laboratory safety procedures to maintain product integrity.

KLOW Blend 80mg Product Specifications

• Purity: ≥99% (HPLC Verified)

• Appearance: Blue lyophilized powder

• Solubility: Refer to Certificate of Analysis for physicochemical properties

Important Note:
This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA. This peptide is not intended to diagnose, treat, cure, or prevent any disease. The bodily introduction into humans or animals is strictly prohibited by law. Any misuse, misbranding, or mislabeling is a violation of federal regulations and may result in legal action under applicable federal, state, or local laws.

References:
Referenced scientific publications include:

• Pickart, L., et al. (2015). “The human tri-peptide GHK and tissue remodeling.” Journal of Biomaterials Science.

• Sikiric, P., et al. (2016). “BPC-157 and wound healing: from experimental models to clinical trials.” Journal of Physiology and Pharmacology.

• Goldstein, A. L., et al. (2005). “Thymosin beta peptides in tissue regeneration and repair.” Annals of the New York Academy of Sciences.

• Myles, I. A., et al. (2013). “The anti-inflammatory peptide KPV modulates immune response.” Journal of Immunology.